Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe

BMC Infectious Diseases

Michael J Doenhoff³  Francisca Mutapi²  Takafira Mduluza⁴  Nicholas Midzi¹  Emily M Dawson³  Norman Nausch⁵ 

[1] Current Address: Department of Medical Microbiology, University of Zimbabwe, P.O. Box A178 Avondale, Harare, Zimbabwe;Institute of Immunology and Infection Research, Centre for Immunity, Infection and Evolution, Ashworth Laboratories, West Mains Road, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JT, UK;School of Life Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK;Department of Biochemistry, University of Zimbabwe, P.O. Box 167Mount Pleasant, Harare, Zimbabwe;Current Address: Pediatric Pneumology and Infectious Diseases Group, Department of General Pediatrics, Neonatology, and Pediatric Cardiology, University Children’s Hospital, 40225 Duesseldorf, Germany

关键词: Neglected tropical disease;    Point-of-care;    Antibody-detection;    Diagnosis;    Schistosomiasis;   

Others  :  1134260
DOI  :  10.1186/1471-2334-14-165

 received in 2013-11-10, accepted in 2014-03-19,  发布年份 2014

【 摘 要 】

Background

Rapid diagnostic tests (RDTs) for use at the point-of-care (POC) are likely to become increasingly useful as large-scale control programmes for schistosomiasis get underway. Given the low sensitivity of the reference standard egg count methods in detecting light infections, more sensitive tests will be required to monitor efforts aimed at eliminating schistosomiasis as advocated by the World Health Assembly Resolution 65.21 passed in 2012.

Methods

A recently developed RDT incorporating Schistosoma mansoni cercarial transformation fluid (SmCTF) for detection of anti-schistosome antibodies in human blood was here evaluated in children (mean age: 7.65 years; age range: 1-12 years) carrying light S. mansoni and S. haematobium infections in a schistosome-endemic area of Zimbabwe by comparison to standard parasitological techniques (i.e. the Kato-Katz faecal smear and urine filtration). Enzyme-linked immunosorbent assays (ELISAs) incorporating S. haematobium antigen preparations were also employed for additional comparison.

Results

The sensitivity of the SmCTF-RDT compared to standard parasitological methods was 100% while the specificity was 39.5%. It was found that the sera from RDT “false-positive” children showed significantly higher antibody titres in IgM-cercarial antigen preparation (CAP) and IgM-soluble egg antigen (SEA) ELISA assays than children identified by parasitology as “true-negatives”.

Conclusions

Although further evaluations are necessary using more accurate reference standard tests, these results indicate that the RDT could be a useful tool for the rapid prevalence-mapping of both S. mansoni and S. haematobium in schistosome-endemic areas. It is affordable, user-friendly and allows for diagnosis of both schistosome species at the POC.

【 授权许可】

   
2014 Nausch et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]WHO: Working to overcome the global impact of neglected tropical diseases, First WHO report on neglected tropical diseases. Geneva: WHO; 2010.
• [2]Gulland A: Governments and drug companies pledge to eliminate 10 neglected tropical diseases by 2020. Br Med J 2012, 344:e773.
• [3]Molyneux DH: The ‘Neglected Tropical Diseases’: now a brand identity; responsibilities, context and promise. Parasit Vectors 2012, 5:23. BioMed Central Full Text
• [4]WHA: Elimination of schistosomiasis (WHA 65.21). Geneva: WHO; 2012.
• [5]WHO: Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: WHO; 2012.
• [6]WHO: Preventive chemotherapy in human helminthiasis. Geneva: WHO; 2006.
• [7]Doenhoff MJ, Chiodini PL, Hamilton JV: Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 2004, 20:35-39.
• [8]Hamilton JV, Klinkert M, Doenhoff MJ: Diagnosis of schistosomiasis: antibody detection, with notes on parasitological and antigen detection methods. Parasitology 1998, 117:S41-S57.
• [9]Bergquist R, Johansen MV, Utzinger J: Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol 2009, 25:151-156.
• [10]Alarcón de Noya BA, Ruiz R, Losada S, Colmenares C, Contreras R, Cesari RM, Noya O: Detection of schistosomiasis cases in low-transmission areas based on coprologic and serologic criteria - The Venezuelan experience. Acta Trop 2007, 103:41-49.
• [11]Zhang Y-Y, Luo J-P, Liu Y-M, Wang Q-Z, Chen J-H, Xu M-X, Wu J, Tu X-M, Wu G-L, Zhang Z-S, Wu H-W: Evaluation of Kato-Katz examination method in three areas with low-level endemicity of schistosomiasis japonica in China: a Bayesian modeling approach. Acta Trop 2009, 112:16-22.
• [12]Kosinski KC, Bosompem KM, Stadecker MJ, Wagner AD, Plummer J, Durant JL, Gute DM: Diagnostic accuracy of urine filtration and dipstick tests for Schistosoma haematobium infection in a lightly infected population of Ghanaian schoolchildren. Acta Trop 2011, 118:123-127.
• [13]Mutapi F: Improving diagnosis of urogenital schistosome infection. Expert Rev Anti Infect Ther 2011, 9:863-865.
• [14]WHO: Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-age children. Geneva: WHO; 2011.
• [15]Sousa-Figueiredo JC, Pleasant J, Day M, Betson M, Rollinson D, Montresor A, Kazibwe F, Kabatereine NB, Stothard JR: Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2010, 2:103-113.
• [16]Mutapi F, Rujeni N, Bourke C, Mitchell K, Appleby L, Nausch N, Midzi N, Mduluza T: Schistosoma haematobium treatment in 1–5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 2011, 5:e1143.
• [17]Enk MJ, Oliveira e Silva G, Rodrigues NB: Diagnostic accuracy and applicability of a PCR system for the detection of Schistosoma mansoni DNA in human urine samples from an endemic area. PLoS One 2012, 7:e38947.
• [18]Ibironke OA, Phillips AE, Garba A, Lamine SM, Shiff C: Diagnosis of Schistosoma haematobium by detection of specific DNA fragments from filtered urine samples. Am J Trop Med Hyg 2011, 84:998-1001.
• [19]WHO: Elimination of schistosomiasis from low-transmission areas: report of a WHO informal consultation. Geneva: World Health Organization; 2008.
• [20]McCarthy JS, Lustigman S, Yang G-J, Barakat RM, García HH, Sripa B, Willingham AL, Prichard RK, Basanez M-G: A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis 2012, 6:e1601.
• [21]Goncalves MML, Barreto MGM, Peralta RHS, Gargioni C, Goncalves T, Igreja RP, Soares MS, Peralta JM: Immunoassays as an auxiliary tool for the serodiagnosis of Schistosoma mansoni infection in individuals with low intensity of egg elimination. Acta Trop 2006, 100:24-30.
• [22]Zhou X-N, Xu J, Chen H-G, Wang T-P, Huang X-B, Lin D-D, Wang Q-Z, Tang L, Guo J-G, Wu X-H, Feng T, Chen J-X, Guo J, Chen S-H, Li H, Wu Z-D, Peeling RW: Tools to support policy decisions related to treatment strategies and surveillance of schistosomiasis japonica towards elimination. PLoS Negl Trop Dis 2011, 5:e1408.
• [23]Zhu YC: Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop 2005, 96:130-136.
• [24]Xu J, Peeling RW, Chen J, Wu X, Wu Z, Wang S, Feng T, Chen S, Li H, Guo J, Zhou X-N: Evaluation of immunoassays for the diagnosis of Schistosoma japonicum infection using archived sera. PLoS Negl Trop Dis 2011, 5:e949.
• [25]Mabey D, Peeling RW, Ustianowski A, Perkins MD: Diagnostics for the developing world. Nat Rev Microbiol 2004, 2:231-240.
• [26]Beyette FR, Kost GJ, Gaydos CA, Weigl BH: Point-of-care technologies for health care. IEEE T Bio-Med Eng 2011, 58:732-735.
• [27]WHO: Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol Rec 2012, 87:33-44.
• [28]French MD, Rollinson D, Basanez M-G, Mgeni AF, Khamis IS, Stothard JR: School-based control of urinary schistosomiasis on Zanzibar, Tanzania: monitoring micro-haematuria with reagent strips as a rapid urological assessment. J Pediatr Urol 2007, 2:364-368.
• [29]Houmsou RS, Kela SL, Suleiman MM: Performance of microhaematuria and proteinuria as measured by urine reagent strips in estimating intensity and prevalence of Schistosoma haematobium infection in Nigeria. Asian Pac J Trop Med 2011, 4:997-1000.
• [30]Bogoch II, Andrews JR, Dadzie Ephraim RK, Utzinger J: Simple questionnaire and urine reagent strips compared to microscopy for the diagnosis of Schistosoma haematobium in a community in northern Ghana. Trop Med Int Health 2012, 17:1217-1221.
• [31]Colley DG, Binder S, Campbell C, King CH, Tchuem Tchuenté L-A, N’Goran EK, Erko B, Karanja DM, Kabatereine NB, Van Lieshout L, Rathbun S: A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni. Am J Trop Med Hyg 2013, 48:426-432.
• [32]Coulibaly JT, Knopp S, N'Guessan NA, Silué KD, Fürst T, Lohourignon LK, Brou JK, N'Gbesso YK, Vounatsou P, N'Goran EK, Utzinger J: Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d'Ivoire. PLoS Negl Trop Dis 2011, 5:e1384.
• [33]Standley CJ, Lwambo NJS, Lange CN, Kariuki HC, Adriko M, Stothard JR: Performance of circulating cathodic antigen (CCA) urine-dipsticks for rapid detection of intestinal schistosomiasis in schoolchildren from shoreline communities of Lake Victoria. Parasit Vectors 2010, 3:7. BioMed Central Full Text
• [34]Tchuem Tchuenté L-A, Kueté Fouodo CJ, Kamwa Ngassam RI, Sumo L, Dongmo Noumedem C, Kenfack CM, Gipwe NF, Nana ED, Stothard JR, Rollinson D: Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl Trop Dis 2012, 6:e1758.
• [35]Shane HL, Verani JR, Abudho B, Montgomery SP, Blackstock AJ, Mwinzi PNM, Butler SE, Karanja DMS, Secor WE: Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in western Kenya. PLoS Negl Trop Dis 2011, 5:e951.
• [36]Sousa-Figueiredo JC, Betson M, Kabatereine NB, Stothard JR: The urine circulating cathodic antigen (CCA) dipstick: a valid substitute for microscopy for mapping and point-of-care diagnosis of intestinal schistosomiasis. PLoS Negl Trop Dis 2013, 7:e2008.
• [37]King CL, Bertsch D: Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis 2013, 7:e2431.
• [38]Stothard JR, Kabatereine NB, Tukahebwa EM, Kazibwe F, Rollinson D, Mathieson W, Webster JP, Fenwick A: Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop 2006, 97:219-228.
• [39]Stothard JR, Sousa-Figueiredo JC, Standley C, Van Dam GJ, Knopp S, Utzinger J, Ameri H, Khamis AN, Khamis IS, Deelder AM, Mohammed KA, Rollinson D: An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. Acta Trop 2009, 111:64-70.
• [40]Smith H, Doenhoff M, Aitken C, Bailey W, Ji M, Dawson E, Gilis H, Spence G, Alexander C, van Gool T: Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections. PLoS Negl Trop Dis 2012, 6:e1815.
• [41]Chand MA, Chiodini PL, Doenhoff MJ: Development of a new assay for the diagnosis of schistosomiasis, using cercarial antigens. Trans R Soc Trop Med Hyg 2010, 104:255-258.
• [42]El Aswad BEDW, Doenhoff MJ, El Hadidi AS, Schwaeble WJ, Lynch NJ: Use of recombinant calreticulin and cercarial transformation fluid (CTF) in the serodiagnosis of Schistosoma mansoni. Immunobiology 2011, 216:379-385.
• [43]Van Gool T, Vetter H, Vervoort T, Doenhoff MJ, Wetsteyn J, Overbosch D: Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S.mansoni egg antigens. J Clin Microbiol 2002, 40:3432-3437.
• [44]Tosswill JHC, Ridley DS: An evaluation of the ELISA for schistosomiasis in a hospital population. Trans R Soc Trop Med Hyg 1986, 80:435-438.
• [45]Coulibaly JT, N'Goran EK, Utzinger J, Doenhoff MJ, Dawson EM: A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies. Parasit Vectors 2013, 6:29. BioMed Central Full Text
• [46]Dawson EM, Sousa-Figueiredo JC, Kabatereine NB, Doenhoff MJ, Stothard JR: Intestinal schistosomiasis in pre school-aged children of Lake Albert, Uganda: diagnostic accuracy of a rapid test for detection of anti-schistosome antibodies. Trans R Soc Trop Med Hyg 2013, 107:639-647.
• [47]Midzi N, Sangweme D, Zinyowera S: Report on the National Soil Transmitted Helminthiasis and Schistosomiasis Survey. Harare, Zimbabwe: Ministry of Health and Child Welfare; 2011.
• [48]Ndhlovu P, Chimbari M, Ndamba J, Chandiwana SK: National Schistosomiasis Survey. Harare, Zimbabwe: Ministry of Health and Child Welfare; 1992.
• [49]WHO: Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 2002., 912i-vi, 1-57, back cover
• [50]Mott KE: A resuable polyamide filter for diagnosis of S. haematobium infection by urine filtration. Bull Soc Pathol Exot Filiales 1983, 76:101-104.
• [51]Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972, 14:397-400.
• [52]Rujeni N, Nausch N, Midzi N, Mduluza T, Taylor TW, Mutapi F: Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies. Parasite Immunol 2012, 34:330-340.
• [53]Alarcón de Noya B, Cesari IM, Losada S, Colmenares C, Balzán C, Hoebeke J, Noya O: Evaluation of alkaline phosphatase immunoassay and comparison with other diagnostic methods in areas of low transmission of schistosomiasis. Acta Trop 1997, 66:69-78.
• [54]Koukanari A, Webster JP, Donnelly CA, Bray BC, Naples J, Bosompem K, Shiff C: Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am J Trop Med Hyg 2009, 80:435-441.
• [55]Booth M, Vounatsou P, N’Goran EK, Tanner M, Utzinger J: The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d’Ivoire. Parasitology 2003, 127:523-531.
• [56]McLaren M, Draper CC, Roberts JM, Minter-Goedbloed E, Ligthart GS, Teesdale CH, Amin MA, Omer AHS, Bartlett A, Voller A: Studies on the enzyme-linked immunosorbent assay (ELISA) test for Schistosoma mansoni infections. Ann Trop Med Parasit 1978, 72:243-253.
• [57]Milner T, Reilly L, Nausch N, Midzi M, Mduluza T, Maizels R, Mutapi F: Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol 2010, 32:710-721.
• [58]Osada Y, Anyan WK, Boamah D, Otchere J, Quartley J, Asigbee JR, Bosompem KM, Kojima S, Ohta N: The antibody responses to adult-worm antigens of Schistosoma haematobium, among infected and resistant individuals from an endemic community in southern Ghana. Ann Trop Med Parasit 2003, 97:817-826.
• [59]Doenhoff MJ: Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance. Parasitol Today 1998, 14:434-435.
• [60]Bligh J, Schramm G, Chiodini PL, Doenhoff MJ: Serological analysis of the outcome of treatment of Schistosoma mansoni infections with praziquantel. Ann Trop Med Parasitol 2010, 104:511-520.